UK secure 30 million doses of Pfizer and BioNTech’s COVID-19 vaccine
Local
The UK has locked in 30 million doses of Pfizer and BioNTech’s COVID-19 vaccine after breaking reports of its 90% effectiveness rate.
The results came from the third stage of human trials involving more than 43,000 participants who received two doses, a placebo or an immunisation jab, which resulted in a 90% success rate in protection from COVID-19.
Pfizer and BioNTech aim to send the vaccine to regulators for approval by the end of November, with the UK’s order of 30 million being enough for 15 million people.
#MaltaDaily